Shop Now
Back to Blog

CBN vs. CBD: Everything You Need To Know

The primary difference between CBD and CBN is that CBD manages daytime stress while CBN targets nighttime sleep maintenance.

CBD is a system-wide generalist that quiets mental noise, but lacks the biological “off-switch” required to physically trigger rest, while CBN is a specialist that engages the sleep cycle directly.

Key Takeaways

  • Both CBN and CBD are non-intoxicating, but should be used for different purposes.
  • CBN binds with both primary cannabinoid receptors (CB1 & CB2), while CBD is a negative allosteric modulator.
  • CBD is promiscuous affecting at least 13 distinct systems.
  • CBN has shown to help with sleep through objective sleep monitoring and clinical sleep trials.

In This Article

Functional Differences

While both cannabinoids are non-intoxicating, CBN & CBD should be used for different reasons.

Daytime vs. Nighttime

  • CBD: Targeted at managing daily psychological calm and stress. It’s anxiolytic, it increases our natural endocannabinoids, and is involved in many different signaling pathways within our body.
  • CBN: Identified as a sleep specialist designed to engage brain-sleep cycles directly.

It should be noted that everybody’s different and cannabinoids affect us all differently.

Endocannabinoid System Differences (Mechanism of Action)

Even though CBN and CBD both are non-intoxicating, they surprisingly use different mechanisms to communicate with our body. How CBN and CBD interact with the our CB1 and CB2 receptors is a strong determinant in how they affect our body.

Endocannabinoid System Signaling

  • CBN Partial Agonist: CBN binds directly to both CB1 (211 nM) and CB2 (126 nM) receptors. CBN’s affinity to CB1 is roughly 10 times lower than THC’s.
  • CBD Negative Allosteric Modulator (NAM): CBD has low affinity for both CB1 and CB2 receptors. Instead, it acts as a NAM, meaning it changes the shape of the receptor to dampen other signals rather than triggering them directly.

Enzymatic Inhibition

CBD also has the added benefit of increasing anandamide (AEA), the body’s natural bliss molecule, by blocking its degradation enzyme FAAH.1 By stopping this breakdown enzyme of AEA, CBD indirectly boosts its levels in the system. AEA is believed to be the cause of the euphoria of “runner’s high”.2

Secondary Pathways Differences

Beyond the primary ECS receptors, CBD and CBN affect a myriad of other pathways.

The Extensive Reach of CBD

CBD is considered “promiscuous,” affecting at least 13 distinct systems:

  • Neurotransmission: GPR55 (the third cannabinoid receptor) and multiple serotonin receptors (5-HT1A, 5-HT2A, 5-HT3).
  • Ion Channel Regulation: GABA-A, Glycine Receptors, α7-nAchR, Nav channels, and T-type Calcium channels.
    • TRP Channels: TRPV1-4, TRPA1, and TRPM8.
  • Intracellular Targets: VDAC1 (Mitochondrial function).

The Sensory Specialization of CBN

CBN has a narrower focus on TRP channels, which allows for targeted sensory relief and physical sedation without the broad-system reach of CBD:

  • TRPA1 “The Wasabi Receptor”: Involved in detecting environmental irritants and noxious (damaging) cold. CBN is an agonist.
  • TRPM8 “The Cold & Menthol Receptor”: Primary sensor for cool temperatures and a target for anti-itch therapies. CBN is an antagonist.

While CBD’s broad reach provides support in many different ways, CBN’s narrower focus allows for higher specificity in triggering the sedative response.

Molecular Architecture Differences (Chemical Structure)

CBD and CBN also have different chemical structures, drastically affecting their molecular stability, which is reflected throughout history.

CBD – The Flexible State

  • CBD features a ring structure missing double bonds, making it flexible and susceptible to heat or environmental degradation.

CBN – The Locked State

  • CBN is an aromatic benzene ring—the most stable structure in organic chemistry. This stability allows it to persist as a biomarker for thousands of years.

This explains why CBN is the cannabinoid that’s able to survive 2,700 years in an ancient tomb or harsh industrial hemp retting from centuries ago.

Clinical Sleep Differences

CBN and CBD have performed differently in sleep studies:

CBN in Sleep Studies

  • Bonn-Miller et al. (2023): This major randomized controlled trial involved 293 participants with poor or very poor sleep. It is one of the largest human trials on minor cannabinoids to date.3
  • Arnold et al. (2024): This study analyzed the effect of CBN on rats using objective polysomnography (brain wave monitoring).4
    • Results: Objective EEG monitoring found that CBN increased the duration of Non-REM (Deep Sleep) with a magnitude comparable to the prescription sleep aid Zolpidem (Ambien). CBN also increased restorative REM sleep, which traditional sedatives typically suppress.

The Takeaway: These CBN sleep studies show in two different ways (human clinical trials and objective brainwave monitoring) that the right amount of CBN can improve sleep.

CBD For Sleep

  • Naryan et al. (2024): A small, but thorough study tracked 30 participants with insomnia daily for two weeks with half taking 150 mg of CBD, while the other half took a placebo to asses the changes.5
    • Results: For most primary sleep metrics—sleep-onset latency (how fast you fall asleep) and wake after sleep onset (time spent awake after initially falling asleep)—CBD was no more effective than the placebo. However, participants in the CBD group did report significantly higher well-being scores compared to the placebo.

The Takeaway: While participants reported significantly higher well-being scores, the objective data confirmed that CBD alone did not physically improve sleep physiology.

The Failed Entourage Effect

The Bonn-Miller et al. study specifically tested combination arms of 20 mg CBN isolated and with 10, 20, or 100 mg CBD. The data showed that adding CBD did not enhance the sleep benefits of CBN. The most significant improvements in sleep maintenance were observed when high-dose CBN acted alone. This highlights an important nuance of the Entourage Effect that often get glossed over by the community; more isn’t always better. Understanding the complex cannabinoid interactions is the key to unlocking their true potential.

CBN vs. CBD: Final Comparison

In conclusion, the science suggests that CBD and CBN are not interchangeable. CBD is your tool for managing the mental noise of the day, but when it comes to the physical maintenance of sleep, the evidence points toward high-dose solo CBN as the clear specialist.

FeatureCBNCBD
Functional RoleSleep specialist System-wide generalist
Endocannabinoid SystemActivates CB1 and CB2 receptorsModulates CB1 and CB2 (NAM)
Increases AEA, the natural “bliss” endocannabinoid
Secondary PathwaysTRP Focus
Activates TRPA1 (Wasabi)
Blocks TRPM8 (Cold & Menthol)		Highly Promiscuous — affects at least 13 different systems
Agonist
Serotonin (5-HT1A, 5-HT2A, 5-HT3)
5-HT3R – NAM / inhibitor
5-HT1AR – Agonist
GABA-A (PAM)
Blocks GPR55 TRPV1-4, TRPA1, and TRPM8.
Agonist
Antagonist
ChemistryLocked (Aromatic); most stable formFlexible; susceptible to light/heat/oxidation
Clinical Sleep20 mg of CBN did significantly improve sleep150 mg of CBD did not statistically improve sleep
a venn diagram of CBN vs CBD

References

  1. Leweke, F M, et al. “Cannabidiol Enhances Anandamide Signaling and Alleviates Psychotic Symptoms of Schizophrenia.” Translational Psychiatry, vol. 2, no. 3, Mar. 2012, pp. e94–e94, www.nature.com/articles/tp201215, https://doi.org/10.1038/tp.2012.15. ↩︎
  2. Siebers, Michael, et al. “Do Endocannabinoids Cause the Runner’s High? Evidence and Open Questions.” The Neuroscientist, vol. 29, no. 3, 26 Jan. 2022, p. 107385842110699, pmc.ncbi.nlm.nih.gov/articles/PMC10159215/, https://doi.org/10.1177/10738584211069981. ↩︎
  3. Bonn-Miller, Marcel O., et al. “A Double-Blind, Randomized, Placebo-Controlled Study of the Safety and Effects of CBN with and without CBD on Sleep Quality.” Experimental and Clinical Psychopharmacology, vol. 32, no. 3, 5 Oct. 2023, pubmed.ncbi.nlm.nih.gov/37796540/#:~:text=Individuals%20receiving%2020%20mg%20CBN, https://doi.org/10.1037/pha0000682. ↩︎
  4. Arnold, Jonathon C., et al. “A Sleepy Cannabis Constituent: Cannabinol and Its Active Metabolite Influence Sleep Architecture in Rats.” Neuropsychopharmacology, vol. 50, 12 Nov. 2024, pp. 586–595, www.nature.com/articles/s41386-024-02018-7, https://doi.org/10.1038/s41386-024-02018-7. ↩︎
  5. Narayan, Andrea J, et al. “Cannabidiol for Moderate-Severe Insomnia: A Randomized Controlled Pilot Trial of 150 Mg of Nightly Dosing.” Journal of Clinical Sleep Medicine, vol. 20, no. 5, 4 Jan. 2024, pp. 753–763, pmc.ncbi.nlm.nih.gov/articles/PMC11063694/, https://doi.org/10.5664/jcsm.10998. ↩︎